These companies are growing rapidly, and their momentum should continue regardless of what happens on Election Day.
News & Analysis: Guardant Health
The company's liquid biopsies could change the way cancer is diagnosed. And make investors rich along the way.
As its stock chart suggests, the liquid biopsy pioneer crushed it on nearly every metric last year.
Here are three compelling reasons to buy healthcare stocks this year.
Three very different areas of healthcare. One big common denominator: great growth prospects.
Both stocks are risky, but for different reasons.
Helping people stricken with illness can be richly rewarding in more ways than one.
These stocks have already more than doubled in 2019. And they could easily do it again in the not-too-distant future.
This leading diagnostic company's stock has nearly quadrupled in value in just over one year.
The diagnostic company reported third-quarter 2019 operating results.